Effect of Arabinoxylan and Rye Kernels on Second Meal Responses

Sponsor
Aarhus University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01583270
Collaborator
University of Aarhus (Other)
15
1
4
6
2.5

Study Details

Study Description

Brief Summary

Sedentary lifestyles and increasing obesity are main causes of the global increase in the prevalence of the metabolic syndrome (Mets) and type 2 diabetic (T2DM). Diet quality, particularly composition of carbohydrate play also a significant role. Barley, oat and rye may in addition to reducing the acute post prandial glucose response also reduce glucose response at a subsequent meal. Purified dietary fibre has been shown to reduce GI and affect levels of satiety hormones. In contrast, our knowledge of the physiological effect of arabinoxylan, which constitute a substantial part of dietary fibre in cereal products, is limited in relation to second meal effects. The investigators also lack knowledge of the second meal effect of arabinoxyan in combination with rye kernels.

Hypothesis: Porridge rich in arabinoxylan and/or whole rye kernels can increase the formation of short chain fatty acids and improve the glycemic response.

The aim of the present study is to compare the effect of porridge test meals based on purified arabinoxylan, rye kernels, a combination of arabinoxylan and rye kernels, and semolina porridge as control on acute postprandial response as well as response at a subsequent standardized meal. The study will be conducted in subjects with the metabolic syndrome. The primary endpoint is glucose response. Secondary endpoints are the following items: insulin, incretins, inflammatory markers, ghrelin, free fatty acids, metabolomics, breath hydrogen and subjective satiety feeling.

This project will improve opportunities for identifying and designing foods with low GI that is particularly suited to people who are at high risk of developing T2DM. The investigators also expect to gain a greater understanding of the metabolic fingerprint, as seen after ingestion of low-GI foods and thereby gain a molecular understanding of how low-GI foods affect health by altering metabolic processes. This will give us a deeper insight into the metabolic processes that are necessary for maintaining normal glucose homeostasis

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Arabinoxylan
  • Dietary Supplement: Rye kernel
  • Dietary Supplement: Arabinoxylan and rye kernels
  • Dietary Supplement: Semolina
N/A

Detailed Description

Using a cross-over design, 15 subjects with Mets will consume test meals containing four different porridges in randomized order. Blood samples will be collected over 2 hours after ingestion of test meals and 2 hours after ingestion of a standard second lunch meal served 4 hours after the test meals. The amount of porridge and the standard lunch are equivalent to 50 g available carbohydrate. Visual Analog Scale (VAS) will be used for determination of subjective satiety feeling and measurements of breath hydrogen will be used as a marker for colon fermentation.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of Arabinoxylan and Rye Kernels on Second Meal Responses in Subjects With the Metabolic Syndrome
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Oct 1, 2012
Actual Study Completion Date :
Oct 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arabinoxylan

Porridge rich in arabinoxylan. 50 g available carbohydrate

Dietary Supplement: Arabinoxylan
Porridge rich in arabinoxylan
Other Names:
  • Dietary fibre.
  • Experimental: rye kernels

    Porridge made from rye kernels. 50 g available carbohydrate

    Dietary Supplement: Rye kernel
    Porridge made of rye kernels
    Other Names:
  • Whole grain. Rye. Kernels.
  • Experimental: arabinoxylan and rye kernels

    Porridge made of rye kernels and arabinoxylan. 50g available carbohydrate

    Dietary Supplement: Arabinoxylan and rye kernels
    Porridgde made of rye kernels and arabinoxylan
    Other Names:
  • dietary fibre. whole grain. rye kernels.
  • Experimental: semolina

    Semoline porridge. 50 g available carbohydrate

    Dietary Supplement: Semolina
    Semoline porridge. control meal.
    Other Names:
  • Wheat.
  • Outcome Measures

    Primary Outcome Measures

    1. Glucose response after second meal [2 hours]

    Secondary Outcome Measures

    1. Plasma response after second meal [2 hours]

      Plasma insulin, incretins, ghrelin, short chain fatty acids, freee fatty acids, inflammation markers, and metabolomics.

    2. Plasma response after test meal [2 hours]

      Plasma glucose, insulin, incretins, short chain fatty acids, free fatty acids, metabolomisc.

    3. Breath hydrogen after second meal [2 hours]

      Breath hydrogen as marker for colon fermentation

    4. Breath hydrogen after testmeal [2 hours]

      Breath hydrogen as marker for colen fermentation

    5. Satiety feeling after second meal [2 hours]

    6. Satiety feeling after test meal [2 hours]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    Central obesity (Female > 94 cm; Male > 80 cm) with two of the following:
    1. fasting triglyceride (> 1,7 mmol/L),

    2. HDL-cholesterol: (Female:< 1,03 mmol/L; Male:< 1,29 mmol/L),

    3. blood pressure (≥ 130/85 mmHg) and

    4. fasting plasma glucose (≥ 5,6 mmol/L)). Subjects who are in medical treatment with lipid and blood pressure-lowering drugs can continue with their habitual treatment provided that the treatment is stable throughout the trial.

    Exclusion Criteria:
    • fasting plasma glucose > 7,0 mmol/l,

    • fasting plasma triglyceride > 5,0 mmol/l,

    • blood pressure > 160/100 mmHg ,

    • legal incapacity , endocrine, cardiovascular or kidney disease,

    • BMI > 38kg/m2,

    • corticosteroid treatment,

    • alcohol or drug addiction and

    • pregnancy or lactation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Aarhus University Hospital Aarhus Denmark 8000

    Sponsors and Collaborators

    • Aarhus University Hospital
    • University of Aarhus

    Investigators

    • Principal Investigator: Kjeld Hermansen, Professor, Aarhus University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    AnneMarie Kruse, Professor Kjeld Hermansen, Aarhus University Hospital
    ClinicalTrials.gov Identifier:
    NCT01583270
    Other Study ID Numbers:
    • CERN-biofuncarb second meal
    • 2101-08-0068
    First Posted:
    Apr 24, 2012
    Last Update Posted:
    Jun 19, 2013
    Last Verified:
    Jun 1, 2013
    Keywords provided by AnneMarie Kruse, Professor Kjeld Hermansen, Aarhus University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 19, 2013